We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research

Product News   Jul 03, 2018

 
Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs

Product News

Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs.

READ MORE

BIA Separations Expands with New Upstream Processing Facility

Product News

Investment in new lab will support integrated optimisation of upstream and downstream process development.

READ MORE


Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE